NCT00520325 A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia Status WITHDRAWN Phase PHASE1
NCT00516451 Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00513656 A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain Status COMPLETED Phase PHASE2
NCT00512642 Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients Status COMPLETED Phase N/A
NCT00509691 Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy Status COMPLETED Phase PHASE1
NCT00506805 Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT00505414 A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine Status TERMINATED Phase PHASE3
NCT00504790 Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer Status COMPLETED Phase PHASE1
NCT00500292 A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00499733 Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer Status TERMINATED Phase EARLY_PHASE1
NCT00499499 A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid Tumors Status SUSPENDED Phase PHASE1
NCT00499291 Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors Status WITHDRAWN Phase NA
NCT00495378 RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia Status TERMINATED Phase PHASE4
NCT00493818 Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693 Status TERMINATED Phase PHASE1
NCT00492830 Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00492388 Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients Status TERMINATED Phase PHASE3
NCT00491946 A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer Status UNKNOWN Phase PHASE4